On November 13th, the Associated Press released an article showing mixed reviews of Arcoxia, the cox-2 inhibitor drug that Merck is hoping to market as a replacement for its drug Vioxx. Merck pulled Vioxx off the market in late 2004 because of studies showing an increased risk of heart attack / cardi...
Merck’s Vioxx Replacement Gets Mixed Reviews
by Christine MillerWednesday, November 22, 2006




















reply